Young infants are not sufficiently protected against measles

May 18, 2010

Young infants appear to have a gap in their protection against measles, from around two to three months old until they are vaccinated at 12 months of age, finds new research published in the British Medical Journal today.

This is because the level of antibodies infants get from their mother drops over time, leaving them susceptible until they are vaccinated.

These findings underline the importance of vaccination at around 12 months of age and support ongoing research into earlier vaccination.

The study involved 207 healthy women-infant pairs recruited from five hospitals in the Province of Antwerp, Belgium from April 2006.

Medical records were used to divide women into two groups: those who had been vaccinated against measles during infancy and those with naturally acquired immunity from measles infection earlier in life.

Levels of measles antibodies were measured from blood samples taken during week 36 of pregnancy, at birth (cord blood), in all infants at 1, 3 and 12 months, and randomly at either 6 or 9 months.

Vaccinated women had significantly fewer antibodies than did naturally immune women. Similarly, infants of vaccinated women had significantly lower antibody levels than infants of naturally immune women.

The presence of maternal antibodies lasted a median time of 2.61 months - 3.78 months for infants of naturally immune women and 0.97 months for infants of vaccinated women.

At six months of age, over 99% of infants of vaccinated women and 95% of infants of naturally immune women had lost their maternal antibodies. And at 9 and 12 months, no positive samples were left in either group.

The researchers found no significant impact of breastfeeding, birth weight, educational level, caesarean section or day care attendance on the duration of maternal antibodies.

This study describes a very early susceptibility to measles in both infants of vaccinated women and women with naturally acquired immunity, say the authors. If future studies show that measles vaccines can be offered with success at an age of less than nine months, policy makers could consider moving forward the routine measles vaccination programme.

For the moment, they suggest early vaccination should be considered during an outbreak or after contact with siblings with measles, and for infants travelling or migrating to endemic areas.

"Most importantly, we confirm the extreme importance of timely administration of the first dose of measles ," they conclude.

Related Stories

Recommended for you

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.